Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.CMS Manual System. http://www.cms.gov/Transmittals/Downloads/R74NCD. pdf (accessed August 9, 2010). CMS. 2009a. ... In Innova- tion Policy and the Economy, edited by A. B. Jaffe, J. Lerner, and S. Stern. Chicago, IL: University of anbsp;...
|Title||:||Rare Diseases and Orphan Products:|
|Author||:||Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy, Institute of Medicine|
|Publisher||:||National Academies Press - 2011-03-03|